|
|
2024's Stock Market Performance
|
|
2024's Stock Market Performance
|
2024's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2024.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 10/01/26.
2024's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2024 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 10/01/26.
2024's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2024 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 10/01/26.
2024's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2024 with the market capitalization, trading under 50 million U.S. dollars, as of 10/01/26.
Who are the 2024's Stock Market Losers?
BIVI
-85.40%
|
|
|
Biovie Inc
Major Pharmaceutical Preparations Industry
BIVI
-85.40%
Biovie Inc is a biotechnology company that aims to develop advanced therapeutic solutions for various diseases. They have a unique business model that focuses on research and development of innovative drugs, strategic partnerships and collaborations with other organizations, along with potential commercialization of their products to generate revenue. Their goal is to create groundbreaking medical treatments that improve the quality of life for patients.
|
LGHL
-85.50%
|
|
|
Lion Group Holding Ltd
Investment Services Industry
LGHL
-85.50%
Lion Group Holding Ltd*s business model focuses on [providing financial services or investment opportunities] to clients through a [diversified portfolio] and strategic partnerships.
|
BNGO
-85.50%
|
|
|
Bionano Genomics Inc
Laboratory Analytical Instruments Industry
BNGO
-85.50%
Bionano Genomics Inc is a biotechnology company specializing in the development and commercialization of genomic analysis tools. Their business model revolves around offering proprietary genome imaging systems that provide high-resolution maps of DNA for researchers and clinicians to study genetic variations and diseases more effectively.
|
BGMS
-85.66%
|
|
|
Bio Green Med Solution Inc
Major Pharmaceutical Preparations Industry
BGMS
-85.66%
Bio Green Med Solution supplies and trades fire safety equipment and protective products.
|
CHGG
-85.66%
|
|
|
Chegg Inc
Educational Services Industry
CHGG
-85.66%
Chegg Inc is an online learning platform that offers a subscription-based service to students, providing them with access to textbooks, study materials, and online tutoring. They generate revenue through subscription fees paid by students and also by partnering with educational institutions to provide services like course materials and online learning tools. Additionally, Chegg has expanded its business model to include acquisition of other education-related companies, further diversifying its offerings.
|
UPXI
-85.73%
|
|
|
Upexi Inc
Legal Cannabis Industry
UPXI
-85.73%
Upexi Inc is a technology-driven company that operates on a platform-based business model. They provide a wide range of services through their platform, connecting customers with various service providers. Their revenue is generated through commissions or transaction fees earned from the services provided on their platform.
|
HLVX
-86.39%
|
|
|
Hillevax Inc
Biotechnology & Pharmaceuticals Industry
HLVX
-86.39%
Hillevax Inc*s business model is centered around a specific product or service that they offer to customers.
|
MBIO
-86.59%
|
|
|
Mustang Bio inc
Major Pharmaceutical Preparations Industry
MBIO
-86.59%
Mustang Bio Inc operates on a business model focused on developing advanced therapies for challenging diseases. They primarily engage in research, development, and commercialization of innovative gene and cell therapies. Mustang Bio Inc aims to provide cutting-edge treatments to patients in need by leveraging its expertise in gene editing technologies and strategic partnerships.
|
LGVN
-86.89%
|
|
|
Longeveron Inc
Major Pharmaceutical Preparations Industry
LGVN
-86.89%
Longeveron Inc*s business model involves the development and commercialization of regenerative medicine products using mesenchymal stem cells for various medical conditions.
|
BTAI
-87.24%
|
|
|
Bioxcel Therapeutics Inc
Major Pharmaceutical Preparations Industry
BTAI
-87.24%
BioXcel Therapeutics Inc. is a biopharmaceutical company that operates using an innovative business model. They utilize artificial intelligence (AI) and big data analytics to identify and develop novel therapies for targeted diseases with unmet medical needs. This approach allows them to leverage data-driven insights to expedite drug discovery and development, potentially increasing the efficiency and success rate of their drug candidates.
|
EDIT
-87.27%
|
|
|
Editas Medicine Inc
Biotechnology & Pharmaceuticals Industry
EDIT
-87.27%
Editas Medicine Inc.*s business model revolves around developing and commercializing transformative genome editing technologies to treat serious diseases.
|
PCSA
-87.51%
|
|
|
Processa Pharmaceuticals Inc
Major Pharmaceutical Preparations Industry
PCSA
-87.51%
Processa Pharmaceuticals Inc is a biopharmaceutical company that operates by developing and commercializing innovative drug candidates for various medical conditions. They focus on advancing treatments through clinical trials, obtaining regulatory approvals, and partnering with other healthcare organizations for distribution and marketing.
|
MBRX
-87.73%
|
|
|
Moleculin Biotech Inc
Major Pharmaceutical Preparations Industry
MBRX
-87.73%
Moleculin Biotech Inc is a biopharmaceutical company that develops innovative cancer therapies by targeting key enzymes and signaling pathways involved in the progression of tumors. Their business model revolves around conducting preclinical and clinical trials to advance their drug candidates, with a focus on maximizing therapeutic impact and commercial potential.
|
ALUR
-87.82%
|
|
|
Allurion Technologies Inc
Medical Equipment & Supplies Industry
ALUR
-87.82%
Allurion Technologies Inc is a medical device company that specializes in developing non-surgical solutions for weight loss. Their business model is centered around providing a comprehensive weight loss program that combines their innovative medical device, the Elipse Balloon, with personalized coaching and support. They target individuals seeking a non-invasive and convenient approach to achieving their weight loss goals.
|
DRCT
-88.06%
|
|
|
Direct Digital Holdings Inc
Advertising Industry
DRCT
-88.06%
Direct Digital Holdings Inc*s business model focuses on the direct-to-consumer sales of health and wellness products.
|
LAZR
-88.50%
|
|
|
Luminar Technologies Inc
Auto & Truck Parts Industry
LAZR
-88.50%
Luminar Technologies Inc is a company that specializes in developing and manufacturing LiDAR sensors and other autonomous driving technologies. Their business model involves selling their products to automotive companies, helping them integrate advanced perception capabilities into their vehicles for autonomous driving applications.
|
|
2,811.36 %
PREV.